公开(公告)号：US20210187002A1

公开(公告)日：2021-06-24

申请号：US16767929

申请日：2018-11-28

Applicant: OSAKA UNIVERSITY

Inventor： Hisashi ARASE ,  Fumiji HIRAYASU ,  Kouyuki HIRAYASU

IPC: A61K31/7088 ,  G01N33/15 ,  C07K14/445 ,  C07K14/705 ,  A61P33/06

Abstract: The present invention provides a new antimalarial drug. The antimalarial drug of the present invention includes: a binding inhibitor that inhibits binding between a RIFIN protein and a leukocyte immunoglobulin-like receptor subfamily B member 1 (LILRB1) protein; an inducer of the binding inhibitor; or an expression inhibitor of RIFIN or LILRB1.